Millennium Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Millennium Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-295,500	Closed	-$34.2M	–	6868
2023 Q3	$34.2M	Sell	295,500 -466,100	-61%	-$50.1M	0.02%	983
2023 Q2	$78.3M	Buy	761,600 +706,100	+1,272%	+$74.5M	0.04%	475
2023 Q1	$6.06M	Sell	55,500 -1,229,000	-96%	-$136M	﹤0.01%	2437
2022 Q4	$146M	Buy	+1,284,500	New	+$107M	0.08%	239
2021 Q2	–	Sell	-2,600	Closed	-$239K	–	7489
2021 Q1	$239K	Sell	2,600 -147,400	-98%	-$12.4M	﹤0.01%	5389
2020 Q4	$11M	Buy	+150,000	New	+$11.1M	0.01%	1628
2017 Q1	–	Sell	-67,500	Closed	-$1.09M	–	4024
2016 Q4	$1.09M	Sell	67,500 -132,500	-66%	-$2.4M	﹤0.01%	2203
2016 Q3	$3.63M	Buy	+200,000	New	+$3.91M	0.01%	1560
2016 Q2	–	Sell	-25,000	Closed	-$414K	–	3800
2016 Q1	$414K	Buy	+25,000	New	+$437K	﹤0.01%	2616
2015 Q4	–	Sell	-100,000	Closed	-$1.98M	–	3950
2015 Q3	$1.98M	Sell	100,000 -100,000	-50%	-$3.16M	﹤0.01%	1909
2015 Q2	$6.95M	Buy	+200,000	New	+$6.1M	0.01%	1186

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's HZNP Position: Q4 2023 in Review

Millennium Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,588,563 shares — an estimated $531M sold.

Millennium Management first reported a position in HZNP in Q2 2013 and held it in 38 quarters. The position peaked at $531M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Millennium Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 4,588,563 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $531M.
Millennium Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 38 quarters.
Millennium Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $531M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.